These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

While many report positive results after taking the medication, experts warn significant weight loss can negatively impact ...

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required ...

Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

This is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on over ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...